DD87029A - - Google Patents

Info

Publication number
DD87029A
DD87029A DD87029DA DD87029A DD 87029 A DD87029 A DD 87029A DD 87029D A DD87029D A DD 87029DA DD 87029 A DD87029 A DD 87029A
Authority
DD
German Democratic Republic
Application number
Publication of DD87029A publication Critical patent/DD87029A/xx

Links

DD87029D DD87029A (ja)

Publications (1)

Publication Number Publication Date
DD87029A true DD87029A (ja)

Family

ID=271611

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87029D DD87029A (ja)

Country Status (1)

Country Link
DD (1) DD87029A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1226830A2 (en) * 2001-01-25 2002-07-31 Pfizer Products Inc. Combination therapy involving a sodium-hydrogen exchanger type 1 or NHE-1 inhibitor for use in treatment of ischemia

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1226830A2 (en) * 2001-01-25 2002-07-31 Pfizer Products Inc. Combination therapy involving a sodium-hydrogen exchanger type 1 or NHE-1 inhibitor for use in treatment of ischemia
EP1226830A3 (en) * 2001-01-25 2003-07-09 Pfizer Products Inc. Combination therapy involving a sodium-hydrogen exchanger type 1 or NHE-1 inhibitor for use in treatment of ischemia

Similar Documents

Publication Publication Date Title
US6348476B1 (en) Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases
RU98116126A (ru) Фармацевтический комбинированный препарат из ингибитора натрий-водородного обмена и лекарственных средств для лечения сердечно-сосудистых заболеваний
CA2369212A1 (en) Combination therapy
DD87029A (ja)